FreeIn the Archives UChicago Cancer Luminaries podcast interviews Odunsi, Le Beau, and Schilsky about running UCCCC October 18, 2024Vol.50 No.39
Cancer History ProjectFree Latino oncology leaders discuss representation in clinical trials, translational research, and health careMesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.” October 11, 2024Vol.50 No.38By Ruben A. Mesa and McKenzie Prillaman
In the aftermath of Helene and Milton, oncologists resort to airlifts to keep treatments on scheduleHelene knocks out Baxter facility, creating shortage of IV fluids October 11, 2024Vol.50 No.38By Claire Marie Porter
Trials & Tribulations Cancer clinical trials shouldn’t discriminate—but they do October 11, 2024Vol.50 No.38By Erin Miller
FreeIn the Archives Less Radical podcast: The origins of modern surgery, radical mastectomy, and the first randomized trials in breast cancer October 11, 2024Vol.50 No.38
Regulatory News ODAC votes decisively in support of PD-L1 expression as predictive biomarker for checkpoint inhibitorsVote may lead to rollback of some indications held by BMS and Merck October 04, 2024Vol.50 No.37By Jacquelyn Cobb
Conversation with The Cancer Letter Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor? October 04, 2024Vol.50 No.37By Claire Marie Porter
Guest Editorial NCI-designated Basic Laboratory Cancer Centers get research done—efficiently October 04, 2024Vol.50 No.37By Ze’ev Ronai
Cancer History ProjectConversation with The Cancer Letter Tom Lynch reflects on discovery of the EGFR mutations’ role in lung cancer October 04, 2024Vol.50 No.37By Paul Goldberg and McKenzie Prillaman
FreeIn the Archives Jeffrey Weber on his career, mentors: “Never ever ever ever blow your cool.” October 04, 2024Vol.50 No.37
